These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 30284727)
1. Multicenter reproducibility of quantitative susceptibility mapping in a gadolinium phantom using MEDI+0 automatic zero referencing. Deh K; Kawaji K; Bulk M; Van Der Weerd L; Lind E; Spincemaille P; McCabe Gillen K; Van Auderkerke J; Wang Y; Nguyen TD Magn Reson Med; 2019 Feb; 81(2):1229-1236. PubMed ID: 30284727 [TBL] [Abstract][Full Text] [Related]
2. Quantitative susceptibility mapping across two clinical field strengths: Contrast-to-noise ratio enhancement at 1.5T. Ippoliti M; Adams LC; Winfried B; Hamm B; Spincemaille P; Wang Y; Makowski MR J Magn Reson Imaging; 2018 Nov; 48(5):1410-1420. PubMed ID: 29659131 [TBL] [Abstract][Full Text] [Related]
3. Rapid automated liver quantitative susceptibility mapping. Jafari R; Sheth S; Spincemaille P; Nguyen TD; Prince MR; Wen Y; Guo Y; Deh K; Liu Z; Margolis D; Brittenham GM; Kierans AS; Wang Y J Magn Reson Imaging; 2019 Sep; 50(3):725-732. PubMed ID: 30637892 [TBL] [Abstract][Full Text] [Related]
4. Reproducibility of quantitative susceptibility mapping in the brain at two field strengths from two vendors. Deh K; Nguyen TD; Eskreis-Winkler S; Prince MR; Spincemaille P; Gauthier S; Kovanlikaya I; Zhang Y; Wang Y J Magn Reson Imaging; 2015 Dec; 42(6):1592-600. PubMed ID: 25960320 [TBL] [Abstract][Full Text] [Related]
5. Quantitative susceptibility mapping (QSM) minimizes interference from cellular pathology in R2* estimation of liver iron concentration. Li J; Lin H; Liu T; Zhang Z; Prince MR; Gillen K; Yan X; Song Q; Hua T; Zhao X; Zhang M; Zhao Y; Li G; Tang G; Yang G; Brittenham GM; Wang Y J Magn Reson Imaging; 2018 Oct; 48(4):1069-1079. PubMed ID: 29566449 [TBL] [Abstract][Full Text] [Related]
6. Multi-centre, multi-vendor reproducibility of 7T QSM and R Rua C; Clarke WT; Driver ID; Mougin O; Morgan AT; Clare S; Francis S; Muir KW; Wise RG; Carpenter TA; Williams GB; Rowe JB; Bowtell R; Rodgers CT Neuroimage; 2020 Dec; 223():117358. PubMed ID: 32916289 [TBL] [Abstract][Full Text] [Related]
7. Clinical Integration of Automated Processing for Brain Quantitative Susceptibility Mapping: Multi-Site Reproducibility and Single-Site Robustness. Spincemaille P; Liu Z; Zhang S; Kovanlikaya I; Ippoliti M; Makowski M; Watts R; de Rochefort L; Venkatraman V; Desmond P; Santin MD; Lehéricy S; Kopell BH; Péran P; Wang Y J Neuroimaging; 2019 Nov; 29(6):689-698. PubMed ID: 31379055 [TBL] [Abstract][Full Text] [Related]
8. Simultaneous quantitative susceptibility mapping (QSM) and R2* for high iron concentration quantification with 3D ultrashort echo time sequences: An echo dependence study. Lu X; Ma Y; Chang EY; He Q; Searleman A; von Drygalski A; Du J Magn Reson Med; 2018 Apr; 79(4):2315-2322. PubMed ID: 29314215 [TBL] [Abstract][Full Text] [Related]
13. Quantitative Susceptibility Mapping at 3 T and 1.5 T: Evaluation of Consistency and Reproducibility. Hinoda T; Fushimi Y; Okada T; Fujimoto K; Liu C; Yamamoto A; Okada T; Kido A; Togashi K Invest Radiol; 2015 Aug; 50(8):522-30. PubMed ID: 25900085 [TBL] [Abstract][Full Text] [Related]
14. Phantom validation of quantitative susceptibility and dynamic contrast-enhanced permeability MR sequences across instruments and sites. Hobson N; Polster SP; Cao Y; Flemming K; Shu Y; Huston J; Gerrard CY; Selwyn R; Mabray M; Zafar A; Girard R; Carrión-Penagos J; Chen YF; Parrish T; Zhou XJ; Koenig JI; Shenkar R; Stadnik A; Koskimäki J; Dimov A; Turley D; Carroll T; Awad IA J Magn Reson Imaging; 2020 Apr; 51(4):1192-1199. PubMed ID: 31515878 [TBL] [Abstract][Full Text] [Related]
15. Quantitative susceptibility mapping (QSM) as a means to monitor cerebral hematoma treatment. Zhang Y; Wei H; Sun Y; Cronin MJ; He N; Xu J; Zhou Y; Liu C J Magn Reson Imaging; 2018 Oct; 48(4):907-915. PubMed ID: 29380461 [TBL] [Abstract][Full Text] [Related]
16. Analysis of different phase unwrapping methods to optimize quantitative susceptibility mapping in the abdomen. Bechler E; Stabinska J; Wittsack HJ Magn Reson Med; 2019 Dec; 82(6):2077-2089. PubMed ID: 31317563 [TBL] [Abstract][Full Text] [Related]
17. Free-breathing high isotropic resolution quantitative susceptibility mapping (QSM) of liver using 3D multi-echo UTE cones acquisition and respiratory motion-resolved image reconstruction. Kang M; Behr GG; Jafari R; Gambarin M; Otazo R; Kee Y Magn Reson Med; 2023 Nov; 90(5):1844-1858. PubMed ID: 37392413 [TBL] [Abstract][Full Text] [Related]
18. On the influence of zero-padding on the nonlinear operations in Quantitative Susceptibility Mapping. Eskreis-Winkler S; Zhou D; Liu T; Gupta A; Gauthier SA; Wang Y; Spincemaille P Magn Reson Imaging; 2017 Jan; 35():154-159. PubMed ID: 27587225 [TBL] [Abstract][Full Text] [Related]
19. Clinical feasibility of brain quantitative susceptibility mapping. Zhang S; Liu Z; Nguyen TD; Yao Y; Gillen KM; Spincemaille P; Kovanlikaya I; Gupta A; Wang Y Magn Reson Imaging; 2019 Jul; 60():44-51. PubMed ID: 30954651 [TBL] [Abstract][Full Text] [Related]
20. Correction of magnetic field inhomogeneity effects for fast quantitative susceptibility mapping. Ngo GC; Bilgic B; Gagoski BA; Sutton BP Magn Reson Med; 2019 Mar; 81(3):1645-1658. PubMed ID: 30387905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]